Evidence map›Paper›PMID 33153400›Full record

ArticleTechnology in cancer research & treatment

Identification of CDCA8, DSN1 and BIRC5 in Regulating Cell Cycle and Apoptosis in Osteosarcoma Using Bioinformatics and Cell Biology.

Qinwen Li, Jie Liang, Bo Chen

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Translational pediatrics · 2024
    Article
  8. Cancer biology & therapy · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mitosis-related geneAnnals of translational medicine · 2021
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Qinwen LiDepartment of Orthopedics, 117899The People's Hospital of China Three Gorges University, The First People's Hospital of Yichang, Yichang City, Hubei, China.
Jie LiangDepartment of Orthopedics, 117899The People's Hospital of China Three Gorges University, The First People's Hospital of Yichang, Yichang City, Hubei, China.
Bo ChenDepartment of Orthopedics, 117899The People's Hospital of China Three Gorges University, The First People's Hospital of Yichang, Yichang City, Hubei, China.
China Three Gorges University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOsteosarcoma is the most common primary tumor of bone, although some molecular markers have been identified, the detailed molecular mechanisms underlying osteosarcoma are currently not fully understood. In the present study, we attempted to identify the potential key genes and pathways in osteosarcoma using bioinformatics analysis.

methodsGSE14359 was downloaded from the GEO database, and analyzed using Limma package. Gene Ontology and pathway enrichment analyses of the DEGs were performed in the DAVID database, followed by the construction of a protein-protein interaction (PPI) network with software Cytoscape, subnetwork modules were subsequently identified and analyzed, and further validation in human osteosarcoma tissues and osteosarcoma cells line was performed.

results964 Differentially expressed genes (DEGs) identified, of which 222 were up-regulated and 742 were down-regulated. Among them, 10 genes (including BIRC5, MAD2L1, Bub1, DSN1, SPC24, CDCA8, STAG2, CENPA, MLF1IP and Mis12) were identified as hub genes and they were mainly enriched in pathways, including mRNA surveillance, RNA transport and PI3K-Akt signaling pathways. Further validation indicated 6 gene (DSN1, BIRC5, CDCA8, MLF1IP, MAD2L1 and SPC24) is highly expressed in osteosarcoma tissues. Among them, CDCA8, DSN1 and BIRC5 significantly promoted the proliferation of osteosarcoma cells in vitro. In terms of mechanism, DSN1 and CDCA8 were mainly involved in cell cycle regulation, while BIRC5 was mainly involved in the regulation of apoptosis pathway.

conclusionsWe identified some key genes and pathways in osteosarcoma, which might be used as molecular targets or diagnostic biomarker for the diagnosis and therapy of osteosarcoma.

Indexed as

ApoptosisCell CycleCell Cycle ProteinsChromosomal Proteins, Non-HistoneComputational BiologyFemaleGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansMaleNeoplasm ProteinsOsteosarcomaPhosphatidylinositol 3-KinasesProtein Interaction MapsSoftwareSurvivinCDCA8 protein, humanCell Cycle ProteinsChromosomal Proteins, Non-HistoneDSN1 protein, humanNeoplasm ProteinsPhosphatidylinositol 3-KinasesSurvivinbioinformatics analysisdifferentially expressed genesosteosarcoma

Identifiers

PMID33153400
PMCPMC7673055
OpenAlexW3096393525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.